7,10-Ethano-1,2,4-triazolo[3,4-a]phthalazine,6-[(5,6-dimethyl-2-pyridinyl)methoxy]-7,8,9,10-tetrahydro-3-(3-methyl-1,2,4-oxadiazol-5-yl)- (202823-32-3)

Identification
Name:	7,10-Ethano-1,2,4-triazolo[3,4-a]phthalazine,6-[(5,6-dimethyl-2-pyridinyl)methoxy]-7,8,9,10-tetrahydro-3-(3-methyl-1,2,4-oxadiazol-5-yl)-
CAS:	202823-32-3
Molecular Formula:	C₂₂H₂₃N₇O₂
Molecular Structure:
Properties
Safety Data

7,10-Ethano-1,2,4-triazolo[3,4-a]phthalazine,7,8,9,10-tetrahydro-3-(3-methyl-1,2,4-oxadiazol-5-yl)-6-(2-pyridinylmethoxy)-
Spiro[furan-3(2H),1'(2'H)-phenanthren]-5(4H)- one,2'-[(1R,2S)-2-(acetyloxy)-1-methyl-3- [(2S,4R)-tetrahydro-4-methyl-5-oxo-2- furanyl]propyl]-3',4',4'a,4'b,5',6',7',8',8'a,9',10',- 10'a-dodecahydro-7'-hydroxy-4'b,8',8',10'atetramethyl-,(1'S,2'R,4'aR,4'bR,7'S,8'aR,- 10'aR)-
1/C10H17NO/c12-10-7-4-8-11(10)9-5-2-1-3-6-9/h9H,1-8H
1/C7H8O3/c1-2-9-7(8)6-4-3-5-10-6/h3-5H,2H2,1H
1/C9H7NO2/c1-10-7-5-3-2-4-6(7)8(11)9(10)12/h2-5H,1H
1/C12H9NO/c14-9-11-3-1-2-4-12(11)10-5-7-13-8-6-10/h1-9
1/C6H6ClNO2/c1-10-6(9)5-4(7)2-3-8-5/h2-3,8H,1H
1/C6H6O3S2/c1-2-9-5(7)4-3-10-11-6(4)8/h3H,2H2,1H
1/C9H15NO/c1-2-4-9(3-1)10-5-7-11-8-6-10/h3H,1-2,4-8H
1/C9H19N/c1-3-9(4-2)10-7-5-6-8-10/h9H,3-8H2,1-2H
1/C10H14O/c1-7(2)10-5-4-9(11)6-8(10)3/h4-7,11H,1-3H
1/C11H10O2/c1-9(12)3-4-10-5-7-11(13-2)8-6-10/h5-8H,1-2H
1/C12H19N/c1-8(2)10-6-5-7-11(9(3)4)12(10)13/h5-9H,13H2,1-4H
1/C11H7ClO2/c12-9-3-1-2-8(6-9)11-5-4-10(7-13)14-11/h1-7
1/C8H6Cl2/c9-8(10)7-5-3-1-2-4-6-7/h1-6
1/C7H5N3OS/c12-7-10-9-6(11-7)5-1-3-8-4-2-5/h1-4H,(H,10,12
1/C8H11NOS/c1-2-4-7(9-10)8-5-3-6-11-8/h3,5-6,10H,2,4H2,1H3/b9-7
1/C10H8N2/c1-2-6-12-10(3-1)9-4-7-11-8-5-9/h1-8
1/C8H5BrCl2/c9-7-3-1-6(2-4-7)5-8(10)11/h1-5
1/C8H10N2O/c1-11-8-4-2-7(3-5-8)6-10-9/h2-6H,9H2,1H3/b10-6